These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9490811

  • 1. Cystic fibrosis transmembrane conductance regulator mediates sulphonylurea block of the inwardly rectifying K+ channel Kir6.1.
    Ishida-Takahashi A, Otani H, Takahashi C, Washizuka T, Tsuji K, Noda M, Horie M, Sasayama S.
    J Physiol; 1998 Apr 01; 508 ( Pt 1)(Pt 1):23-30. PubMed ID: 9490811
    [Abstract] [Full Text] [Related]

  • 2. Expression of CFTR controls cAMP-dependent activation of epithelial K+ currents.
    Loussouarn G, Demolombe S, Mohammad-Panah R, Escande D, Baró I.
    Am J Physiol; 1996 Nov 01; 271(5 Pt 1):C1565-73. PubMed ID: 8944640
    [Abstract] [Full Text] [Related]

  • 3. Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator.
    McNicholas CM, Guggino WB, Schwiebert EM, Hebert SC, Giebisch G, Egan ME.
    Proc Natl Acad Sci U S A; 1996 Jul 23; 93(15):8083-8. PubMed ID: 8755607
    [Abstract] [Full Text] [Related]

  • 4. A functional CFTR-NBF1 is required for ROMK2-CFTR interaction.
    McNicholas CM, Nason MW, Guggino WB, Schwiebert EM, Hebert SC, Giebisch G, Egan ME.
    Am J Physiol; 1997 Nov 23; 273(5):F843-8. PubMed ID: 9374850
    [Abstract] [Full Text] [Related]

  • 5. Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells.
    Insuk SO, Chae MR, Choi JW, Yang DK, Sim JH, Lee SW.
    Int J Impot Res; 2003 Aug 23; 15(4):258-66. PubMed ID: 12934053
    [Abstract] [Full Text] [Related]

  • 6. Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents.
    Sheppard DN, Welsh MJ.
    J Gen Physiol; 1992 Oct 23; 100(4):573-91. PubMed ID: 1281220
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of ATP-sensitive K+ channels by substituted benzo[c]quinolizinium CFTR activators.
    Prost A, Dérand R, Gros L, Becq F, Vivaudou M.
    Biochem Pharmacol; 2003 Aug 01; 66(3):425-30. PubMed ID: 12907241
    [Abstract] [Full Text] [Related]

  • 8. Cystic fibrosis transmembrane conductance regulator (CFTR) confers glibenclamide sensitivity to outwardly rectifying chloride channel (ORCC) in Hi-5 insect cells.
    Julien M, Verrier B, Cerutti M, Chappe V, Gola M, Devauchelle G, Becq F.
    J Membr Biol; 1999 Apr 01; 168(3):229-39. PubMed ID: 10191357
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl- channels by non-sulphonylurea hypoglycaemic agents.
    Cai Z, Lansdell KA, Sheppard DN.
    Br J Pharmacol; 1999 Sep 01; 128(1):108-18. PubMed ID: 10498841
    [Abstract] [Full Text] [Related]

  • 10. Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells.
    Babenko AP, Gonzalez G, Aguilar-Bryan L, Bryan J.
    Circ Res; 1998 Nov 30; 83(11):1132-43. PubMed ID: 9831708
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells.
    Gopalakrishnan M, Molinari EJ, Shieh CC, Monteggia LM, Roch JM, Whiteaker KL, Scott VE, Sullivan JP, Brioni JD.
    Br J Pharmacol; 2000 Apr 30; 129(7):1323-32. PubMed ID: 10742287
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Metabolic inhibition impairs ATP-sensitive K+ channel block by sulfonylurea in pancreatic beta-cells.
    Mukai E, Ishida H, Kato S, Tsuura Y, Fujimoto S, Ishida-Takahashi A, Horie M, Tsuda K, Seino Y.
    Am J Physiol; 1998 Jan 30; 274(1):E38-44. PubMed ID: 9458745
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of glibenclamide on cystic fibrosis transmembrane regulator, swelling-activated, and Ca(2+)-activated Cl- channels in mammalian cardiac myocytes.
    Yamazaki J, Hume JR.
    Circ Res; 1997 Jul 30; 81(1):101-9. PubMed ID: 9201033
    [Abstract] [Full Text] [Related]

  • 17. Dual action of ZD6169, a novel K(+) channel opener, on ATP-sensitive K(+) channels in pig urethral myocytes.
    Teramoto N, Yunoki T, Takano M, Yonemitsu Y, Masaki I, Sueishi K, Brading AF, Ito Y.
    Br J Pharmacol; 2001 May 30; 133(1):154-64. PubMed ID: 11325805
    [Abstract] [Full Text] [Related]

  • 18. Modulation of K+ channels by intracellular ATP in human neocortical neurons.
    Jiang C, Haddad GG.
    J Neurophysiol; 1997 Jan 30; 77(1):93-102. PubMed ID: 9120601
    [Abstract] [Full Text] [Related]

  • 19. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.
    Rainbow RD, James M, Hudman D, Al Johi M, Singh H, Watson PJ, Ashmole I, Davies NW, Lodwick D, Norman RI.
    Biochem J; 2004 Apr 01; 379(Pt 1):173-81. PubMed ID: 14672537
    [Abstract] [Full Text] [Related]

  • 20. External ATP and its analogs activate the cystic fibrosis transmembrane conductance regulator by a cyclic AMP-independent mechanism.
    Cantiello HF, Prat AG, Reisin IL, Ercole LB, Abraham EH, Amara JF, Gregory RJ, Ausiello DA.
    J Biol Chem; 1994 Apr 15; 269(15):11224-32. PubMed ID: 7512560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.